An observational study in Loneliness, sponsored by José Joaquín Mira Solves. Completed at 1 site in Spain. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-04-01.
Sponsored by José Joaquín Mira Solves · Observational
Creating a map of the magnitude of the problem and the response of primary care to unwanted loneliness among the elderly, stratifying different needs based on place of residence and proximity to available assistance programs to address this issue, which, due to its scale, calls for collaboration among various institutions, disciplines, and experiences.
José Joaquín Mira Solves is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Population aged 65 or older who attend one of the 10 primary care centers participating in the provinces of Alicante and Valencia between March 1, 2022, and December 31, 2023.
Exclusion Criteria:
extraction of data
NH
Number of hospitalizations
Time frame: 21 months
NFMV
Number of family medicine visits
Time frame: 21 months
NPCNV
Number of primary care nursing visits
Time frame: 21 months
NPSWV
Number of primary care social work visits
Time frame: 21 months
NFPV
Number of primary care physiotherapy visits
Time frame: 21 months
NCPHV
Number of primary care home consultations
Time frame: 21 months
NCEPV
Number of primary care emergency consultations
Time frame: 21 months
NHD
Number of hospitalization days
Time frame: 21 months
NTDMGE
Number of total daily medications (general and related to emotional condition)
Time frame: 21 months
NTEM
Number of total daily medications (related only to emotional condition)
Time frame: 21 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
José Joaquín Mira Solves